After hours
You're reading the free version. Trader adds the live tape and alerts. Start tracking
Disposition
Calculated transaction value
$188.69K

Snyder Mark Howard SVP, Chief Legal Officer

Transaction date Jun 12, 2026
Public filing date Jun 15, 2026
Filing lag Filed 3 days later

HALO daily price context

Close on/before transaction
$69.5 Jun 12, 2026
First close after public filing
$69.64 Jun 16, 2026
30-day return after filing
+8.87% Through Jul 15, 2026

Source details

Reported owner
Not disclosed
Source asset code
Security
Security
Common Stock
Quantity / price
2,715 shares @ $69.5
SEC ownership
Direct
Transaction code
F
Form
4
Filing identifier
0001159036-26-000077
Filing cohort

Transactions in this filing

Showing 3 of 3
Trades
3
Issuers
1
Estimated value
$188.69K
Buys / sales
0 / 0
Transactions reported in the same official filing
Issuer Transaction Traded Value
Halozyme Therapeutics, Inc. HALO Current Disposition Jun 12, 2026 $188.69K
Halozyme Therapeutics, Inc. HALO Exercise Jun 12, 2026 $0
Halozyme Therapeutics, Inc. HALO Exercise Jun 12, 2026 $0